February 04, 2022

How Cytovale is set to transform the fight against Sepsis

Sepsis is the leading cause of death worldwide according to the World Health Organization, killing 11 million people each year, many of them children, and disabling many more. But while speedy diagnosis and treatment is crucial in combating sepsis, the medical profession has no reliable and speedy test for the condition...

Read More
June 17, 2021

Cytovale Aiming to Enter Sepsis Testing Market With Rapid, Direct-From-Blood, Point-of-Care Platform

Diagnostic test developer Cytovale this month took a step closer to its goal of commercializing a host-response test that has the potential to provide an assessment for the risk of sepsis in 10 minutes.

Read More


Additional Publications


Additional Resources

Small Scientific Journal

Focusing Cells to Single Streams

Read More
Microsystems & Nanoengineering

Biophysical Classification of Cell Differentiation State

Read More
Nature - Scientific Reports

Introducing the Cell Mechanome

Read More
Annual Review of Biomedical Engineering

New Opportunities for Rapid Mechanical Measurement of Cells

Read More
Current Opinion in Biotechnology

Advances in high-throughput single-cell microtechnologies

Read More
Do you have an application for our technology?

Contact Us